期刊
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
卷 151, 期 2, 页码 231-234出版社
BLACKWELL PUBLISHING
DOI: 10.1111/j.1365-2249.2007.03559.x
关键词
clinical trials; first-in-man; immunotherapy; phase 1; TGN1412
类别
资金
- Wellcome Trust [074731] Funding Source: Medline
Current immunology research is generating many new approaches to immunotherapy. However, the recent disaster surrounding the testing of TGN1412, has unsettled regulators and the pharmaceutical industry regarding new immunotherapies and highlighted the complexities of conducting clinical trials with agents that target the immune system. Here we discuss the critical role for immunologists in ensuring that the development of new immunotherapies continues.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据